Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Stroke

• Publication date

  2006-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.STR.0000198839.61112.EEPMID 16385088
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.

  2004cited by this paper
• Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

  2003cited by this paper
• Atrial Fibrillation and the Prothrombotic State in the Elderly: The Rotterdam Study

  2003cited by this paper
• Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis.

  2002cited by this paper
• Silent Cerebral Microbleeds on T2*-Weighted MRI: Correlation with Stroke Subtype, Stroke Recurrence, and Leukoaraiosis

  2002cited by this paper
• ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conference

  2001cited by this paper
• Significance of Earlier Carotid Atherosclerosis for Stroke Subtypes

  2001cited by this paper
• Warfarin for stroke prevention still underused in atrial fibrillation: patterns of omission.

  2000cited by this paper
• Cardioembolic vs. Noncardioembolic Strokes in Atrial Fibrillation: Frequency and Effect of Antithrombotic Agents in the Stroke Prevention in Atrial Fibrillation Studies

  2000cited by this paper
• Preventing stroke in patients with atrial fibrillation.

  2000cited by this paper
• Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation : a multicenter, prospective, randomized trial. Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study Group.

  2000cited by this paper
• Risk factors for thromboembolism in patients with paroxysmal atrial fibrillation.

  2000cited by this paper
• Prevalence and clinical characteristics of patients with atrial fibrillation: analysis of 20,000 cases in Japan.

  2000cited by this paper
• Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation

  1999cited by this paper
• Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators.

  1999cited by this paper
• Preventing stroke in patients with atrial fibrillation.

  1999cited by this paper
• Activation of the hemostatic mechanism after pharmacological cardioversion of acute nonvalvular atrial fibrillation.

  1997cited by this paper
• Contrast sonography for detection of vesicoureteral reflux.

  1994cited by this paper
• Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study

  1994cited by this paper
• Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study.

  1994cited by this paper
• Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation : stroke prevention in atrial fibrillation II study. Commentary

  1994cited by this paper
• Stroke Prevention in Atrial Fibrillation Study: Final Results

  1991cited by this paper
• A multicenter prospective randomized trial

  1991cited by this paper
• Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

  1989cited by this paper
• Intracerebral hemorrhage in a Japanese community, Hisayama: incidence, changing pattern during long-term follow-up, and related factors.

  1988cited by this paper

• Combined Aspirin Study for Mechanical Prosthetic Valve in Kyushu and Ryukyu by Inter-University Hospital Network (ASPIRIN-Trial).

  2026cites this paper
• Ask the consultant: Stroke

  2025cites this paper
• Evaluation of the Use of Primary Prevention Aspirin in Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant for Stroke Prevention.

  2025cites this paper
• Early Prediction of Paroxysmal Atrial Fibrillation in Patients With Acute Stroke Using the BANQMR Score

  2025cites this paper
• Patients with Atrial Fibrillation are Unlikely to Benefit from Aspirin Monotherapy

  2024cites this paper
• Gastrointestinal bleeding in elderly patients with atrial fibrillation: prespecified All Nippon Atrial Fibrillation in the Elderly (ANAFIE) Registry subgroup analysis

  2024cites this paper
• Early Antithrombotic Therapy in Acute Ischemic Stroke

  2024cites this paper
• Impact of prior use of antiplatelet agents and non-vitamin K antagonist oral anticoagulants on stroke outcomes among endovascular-treated patients with high pre-stroke CHA2DS2-VASc score

  2023cites this paper
• Oral Anticoagulation in Patients With Advanced Chronic Kidney Disease and Atrial Fibrillation: Beyond Anticoagulation.

  2023cites this paper
• Direct Oral Anticoagulants Would Be Best Choice for Atrial Fibrillation Patients After Coronary Stenting: Retrospective Study in a Japanese Population.

  2023cites this paper
• 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2023cites this paper
• 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2023cites this paper
• Stroke Risk Stratification in Patients With Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting

  2022cites this paper
• Direct Oral Anticoagulants in Asian Patients with Atrial Fibrillation: Consensus Recommendations by the Asian Pacific Society of Cardiology on Strategies for Thrombotic and Bleeding Risk Management

  2021cites this paper
• Predicting major bleeding among hospitalized patients using oral anticoagulants for atrial fibrillation after discharge

  2021cites this paper
• Age-Related Clinical Outcomes of Patients with Non-Valvular Atrial Fibrillation: Insights from the COOL-AF Registry

  2021cites this paper
• Thromboembolism in Patients with Hypertrophic Cardiomyopathy

  2021cites this paper
• Aspirin Use and Risk of Subdural Hematoma: Updated Meta-Analysis of Randomized Trials.

  2021cites this paper
• Antiplatelet Therapy in Patients with Atrial Fibrillation: A Systematic Review and Metaanalysis of Randomized Trials.

  2021cites this paper
• Comparative risk for intracranial hemorrhage related to new oral anticoagulants

  2021cites this paper
• Diagnosis, Prevention, and Treatment of Cardiovascular Diseases in People With Type 2 Diabetes and Prediabetes　- A Consensus Statement Jointly From the Japanese Circulation Society and the Japan Diabetes Society.

  2020cites this paper
• Comparative efficacy and safety of warfarin care bundles and novel oral anticoagulants in patients with atrial fibrillation: a systematic review and network meta-analysis

  2020cites this paper
• Diagnosis, prevention, and treatment of cardiovascular diseases in people with type 2 diabetes and prediabetes: a consensus statement jointly from the Japanese Circulation Society and the Japan Diabetes Society

  2020cites this paper
• Comparative Outcomes Between Direct Oral Anticoagulants, Warfarin, and Antiplatelet Monotherapy Among Chinese Patients with Atrial Fibrillation: A Population-Based Cohort Study

  2020cites this paper
• Clinical benefits and risks of antithrombotic therapy in patients with atrial fibrillation with comorbidities - A report from the CHART-2 Study.

  2020cites this paper
• Antithrombotic therapy for stroke prevention in patients with atrial fibrillation in Japan

  2020cites this paper
• Age threshold for anticoagulation in patients with atrial fibrillation: A Swedish nationwide observational study.

  2020cites this paper
• Anticoagulation Drug Trials for Stroke Prevention in Atrial Fibrillation

  2019cites this paper
• Real-World Antithrombotic Therapy in Atrial Fibrillation Patients with a History of Percutaneous Coronary Intervention.

  2019cites this paper
• Should This Patient Be Screened for Atrial Fibrillation?

  2019cites this paper
• Characteristics of Japanese Patients with Nonvalvular Atrial Fibrillation on Anticoagulant Treatment: A Descriptive Analysis of J-dabigatran Surveillance and JAPAF Study

  2019cites this paper
• Prescription status of oral anticoagulants in patients with acute cerebral infarction with non-valvular atrial fibrillation at the time of stroke onset.

  2019cites this paper
• Modulating Inflammation in Monocytes Using Capillary Fiber Organic Electronic Ion Pumps

  2019cites this paper
• Primary Prevention of Cardiovascular Events with Aspirin: Toward More Harm than Benefit—A Systematic Review and Meta-Analysis

  2019cites this paper
• Monotherapy of acetylsalicylic acid or warfarin for prevention of ischemic stroke in low-risk atrial fibrillation: A Easter Asian population-based study

  2019cites this paper
• Rate of anticoagulant use, and factors associated with not prescribing anticoagulant in older Thai adults with non-valvular atrial fibrillation: A multicenter registry

  2019cites this paper
• Antithrombotic Therapy for Secondary Stroke Prevention

  2018cites this paper
• ‘Choosing Wisely’ culture among Brazilian cardiologists

  2018cites this paper
• Stroke Prevention in Patients With Atrial Fibrillation: A Systematic Review Update

  2018cites this paper
• Management of Common Arrhythmia in the Neurological Intensive Care Unit

  2018cites this paper
• Physician decision making in anticoagulating atrial fibrillation: a prospective survey of a physician notification system for atrial fibrillation detected on cardiac implantable electronic devices of patients at increased risk of stroke.

  2018cites this paper
• Antiplatelet and Anticoagulant Therapy for Stroke Prevention in Patients With Non-Valvular Atrial Fibrillation: Evidence Based Strategies and New Developments Tratamiento antiagregante plaquetario y anticoagulante para la prevención del ictus en pacientes con fibrilación auricular no valvular: nue

  2018cites this paper
• Stroke Prevention in Atrial Fibrillation: Focus on Asian Patients

  2018cites this paper
• Thoracoscopic stapler-and-loop technique for left atrial appendage closure in nonvalvular atrial fibrillation: Mid-term outcomes in 201 patients.

  2018cites this paper
• Stroke Prevention in Atrial Fibrillation

  2018cites this paper
• Screening for Atrial Fibrillation With Electrocardiography: Evidence Report and Systematic Review for the US Preventive Services Task Force

  2018cites this paper
• Physician decision making in anticoagulating atrial fibrillation: a prospective survey of a physician notification system for atrial fibrillation detected on cardiac implantable electronic devices of patients at increased risk of stroke

  2018cites this paper
• Bleeding risk with dabigatran, rivaroxaban, warfarin, and antiplatelet agent in Asians with non-valvular atrial fibrillation

  2017cites this paper
• Antiplatelet Therapy in Patients with Coronary Artery Disease

  2017cites this paper
• Mechanisms, Clinical Significance, and Prevention of Cognitive Impairment in Patients With Atrial Fibrillation.

  2017cites this paper
• Anticoagulant and antiarrhythmic agents for atrial fibrillation

  2017cites this paper
• 2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation

  2017cites this paper
• The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation: A Review

  2017cites this paper
• Role of Antiplatelet Therapy in Stroke Prevention in Patients With Atrial Fibrillation

  2017cites this paper
• INSTRUCTIONS ON THE ANNOTATION OF PDF FILES

  2017cites this paper
• Optimizing the use of oral anticoagulant therapy for atrial fibrilation in primary care: a pharmacist-led intervention

  2017cites this paper
• Risk analysis of new oral anticoagulants for gastrointestinal bleeding and intracranial hemorrhage in atrial fibrillation patients: a systematic review and network meta-analysis

  2017cites this paper
• Prevalence and characteristics of antiplatelet therapy without overt occlusive vascular disease among hospitalized older patients

  2017cites this paper
• Patients with atrial fibrillation and outcomes of cerebral infarction in those with treatment of warfarin versus no warfarin with references to CHA2DS2-VASc score, age and sex - A Swedish nationwide observational study with 48 433 patients

  2017cites this paper
• Systematic review and network meta-analysis of stroke prevention treatments in patients with atrial fibrillation

  2016cites this paper
• Stroke and death in elderly patients with atrial fibrillation in Japan compared with the United Kingdom

  2016cites this paper
• Nine-Year Trend of Anticoagulation Use, Thromboembolic Events, and Major Bleeding in Patients With Non-Valvular Atrial Fibrillation　- Shinken Database Analysis.

  2016cites this paper
• Selection of Antithrombotic Therapy in Patients with Atrial Fibrillation and Percutaneous Coronary Intervention.

  2016cites this paper
• Caracterización de la fibrilación auricular en el Servicio de Medicina Interna del Hospital Nacional San Rafael (El Salvador)

  2016cites this paper
• The Benefit and Safety of Aspirin for Primary Prevention of Ischemic Stroke: A Meta-Analysis of Randomized Trials

  2016cites this paper
• Primary prevention of cardiovascular disease

  2016cites this paper
• Temporal Trends in Stroke Severity and Prior Antithrombotic Use Among Acute Ischemic Stroke Patients in Japan.

  2016cites this paper
• Antiplatelet therapy for preventing stroke in people with atrial fibrillation

  2016cites this paper
• Antithrombotic therapy in patients with non-valvular atrial fibrillation in Southern Sweden: A population-based cohort study.

  2016cites this paper
• Comparative Effectiveness of Interventions for Stroke Prevention in Atrial Fibrillation: A Network Meta‐Analysis

  2016cites this paper
• Secondary Prevention After Cardioembolic Stroke

  2016cites this paper
• 2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation.

  2016cites this paper
• Development and validation of a decision aid for choosing among antithrombotic agents for atrial fibrillation.

  2016cites this paper
• Antithrombotic and Anticoagulant Therapy for Atrial Fibrillation.

  2016cites this paper
• Individualized approaches to thromboprophylaxis in atrial fibrillation.

  2016cites this paper
• Platelets: Small in Size But Essential in the Regulation of Vascular Homeostasis - Translation From Basic Science to Clinical Medicine.

  2015cites this paper
• The Impact of Novel Anticoagulants: Should All AF Patients Now Be Anticoagulated?

  2015cites this paper
• Clinical and Safety Outcomes of Oral Antithrombotics for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Network Meta-analysis.

  2015cites this paper
• Antiplatelet therapy in Japanese patients with atrial fibrillation without oral anticoagulants: Pooled analysis of Shinken Database, J-RHYTHM registry and Fushimi AF registry.

  2015cites this paper
• Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: time for a reappraisal.

  2015cites this paper
• Aspirin Use in Adults: Cancer, All-Cause Mortality, and Harms

  2015cites this paper
• 心房細動例における新規抗凝固薬｢ダビガトラン｣の安全性と有効性に関する検討

  2015cites this paper
• Development and Validation of a Decision Aid for Choosing Among Anticoagulants for Atrial Fibrillation

  2015cites this paper
• Atrial fibrillation and heart failure: update 2015.

  2015cites this paper
• How to walk the tightrope between harm and protection in selecting the optimal antiplatelet treatment strategy after transcatheter left atrial appendage occlusion

  2015cites this paper
• New insights into the mechanisms of action of aspirin and its use in the prevention and treatment of arterial and venous thromboembolism

  2015cites this paper
• Haemostasis and Thrombosis: Observations on Atrial Fibrillation and Platelets

  2015cites this paper
• Asian strategy for stroke prevention in atrial fibrillation.

  2015cites this paper
• A novel approach indirectly comparing benefit-risk balance across anti-thrombotic therapies in patients with atrial fibrillation.

  2015cites this paper
• Clinical significance of non-vitamin K antagonist oral anticoagulants in the management of atrial fibrillation.

  2015cites this paper
• Systematic Review of Observational Studies Assessing Bleeding Risk in Patients with Atrial Fibrillation Not Using Anticoagulants

  2014cites this paper
• Antithrombotic and anticoagulant therapy for atrial fibrillation.

  2014cites this paper
• Drug Therapies for Stroke Prevention in Atrial Fibrillation: An Historical Perspective.

  2014cites this paper
• Comparison between CHADS2 and CHA2DS2-VASc score for risk stratification of ischemic stroke in Japanese patients with non-valvular paroxysmal atrial fibrillation not receiving anticoagulant therapy.

  2014cites this paper
• Late-phase thromboembolism after catheter ablation for paroxysmal atrial fibrillation.

  2014cites this paper
• Inappropriate use of oral anticoagulants for patients with atrial fibrillation.

  2014cites this paper
• 종 설 : 새로운 항응고제의 임상적 적용: 비판막성 심방세동 환자에서 뇌졸중의 예방을 위한 새로운 항응고제의 사용을 중심으로

  2014cites this paper
• Improving anticoagulation in atrial fibrillation: observational study in three primary care trusts.

  2014cites this paper
• An Explanation of Recommendation Differences: Illustrations from Recent Atrial Fibrillation Guidelines

  2014cites this paper
• University of Birmingham Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation

  2014cites this paper